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detected during the early febrile peri-
od. The male patient still had fever
when the needle accident occurred,
and the needle was contaminated.
Infectious disease specialists and
other physicians should recognize that
vector-borne diseases, such as dengue
and malaria, are potentially life threat-
ening. Therefore, they should consider
these diseases in the differential diag-
nosis of febrile patients returning from
tropical countries. In most patients,
dengue fever resolves without hemo-
concentration, an indication of dengue
hemorrhagic fever. Nosocomial trans-
mission of dengue viruses is not a
common event, however, physicians
must consider these diseases.
These unique cases demonstrate
the possible introduction and trans-
mission of exotic tropical viruses in a
country within temperate zones; all
that is needed are competent vectors.
Whereas A. aegypti is not endemic in
Europe, it could be introduced. The A.
albopictus mosquitoes, an invader
from Asia, already exists there, albeit
in isolated areas (10). Patients return-
ing from distant regions should be
treated with increased attention and
care. Although dengue viruses are
rarely transmitted person to person,
this incident emphasizes the impor-
tance of having reliable and rapid
diagnostic methods available for early
detection of imported infections with
exotic viral agents.
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To the Editor: Crimean-Congo
hemorrhagic fever (CCHF) virus,
genus Nairovirus, family Bunyviridae,
is transmitted to mammals and birds
by ticks. Hyalomma ticks, the primary
vectors in CCHF transmission, are
widespread throughout Europe, Asia,
the Middle East, and Africa; evidence
of CCHF virus has been found in all
these regions. CCHF in humans is an
acute viral disease that is transmitted
by the bite of infected ticks, direct
contact with blood or infected tissues
from viremic animals, and direct con-
tact with the blood or secretions of an
infected person (1). 
On January 26, 2003, a 22-year-
old shepherd was treated at a health
post in the Popenguine District, 60 km
south of Dakar, Sénégal; he reported
fever, epistaxis, arthralgia, myalgia of
the lower limbs, and dark urine for the
past 2 days. Without biologic confir-
mation of the infection, he was treated
for malaria with two intravenous
injections of quinine, followed by oral
administration of chloroquine. 
On January 31, the patient had a
temperature of 39°C, conjunctival
jaundice, bleeding gums, and was
vomiting blood. He was seen again at
the health post and was given antimi-
crobial drugs, intravenous quinine,
and vitamin K; the next day, the
bleeding stopped and the fever sub-
sided. A serum sample was sent to the
World Health Organization
Collaborative Centre for Arboviruses
and Viral Hemorrhagic Fevers at the
Institut Pasteur, Dakar. Tests for anti-
CCHF specific immunoglobulin (Ig)
M antibody by enzyme-linked
immunosorbent assay (ELISA) were
positive, and CCHF virus by isolation
on cell cultures (AP61 and Vero cells)
and reverse transcriptase-polymerase
chain reaction (RT-PCR) were nega-
tive. From January 31 to February 10,
the IgM titer increased from 1/3,200
to >1/12,800 and IgG titer increased
from 1/200 to 1/6,400. 
Examination of the patient on
February 10 showed he had recovered
without sequelae, and no trace of tick
bites was found. The patient stated
that he had not traveled, noticed any
tick bites, slaughtered any animals, orLETTERS
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been in contact with people with fever
for several weeks before his illness.
He lived in close proximity to goats
and cattle, but no blood samples were
taken from these animals. Although
no ticks were found on nearby goats,
10 Amblyomma and Hyalomma ticks
were collected from three cattle. Ticks
were negative for CCHF virus isola-
tion on suckling mice and RT-PCR
amplification.
No other case of fever accompa-
nied by hemorrhage was reported in
the area, and none of the patient’s 14
close contacts became ill. Of the four
close contacts from whom blood sam-
ples were taken, analyses for IgM and
IgG antibodies against CCHF virus
were negative by ELISA. 
While no clinical case of CCHF
has ever been reported in Senegal,
studies dating from 1969 indicate that
CCHF virus had been found in vari-
ous locations in the country (2,3). In
the village of Bandia, in the same dis-
trict where the reported case was
observed, a study conducted from
1986 to 1988 showed a prevalence of
anti-CCHF IgG of 3.2% in the human
population (4). Another study, con-
ducted in the same area from 1989 to
1992, showed seroconversions for
several ruminants and isolated the
virus from ticks (5).
During CCHF outbreaks, an aver-
age of 30% of people who had the dis-
ease died (case-fatality ratio). It is
often discovered during nosocomial
outbreaks, as was the case in
Mauritania, a country on Sénégal’s
northern border, in 2003 (P. Nabeth,
unpub. data). To prevent outbreaks of
CCHF, public awareness campaigns
aimed at the populations most at
risk—livestock farmers, butchers, and
health personnel—must be conduct-
ed, and the epidemiologic alert sys-
tems must be strengthened. In addi-
tion, conditions that enhance mainte-
nance of the virus in nature and its
transmission to humans must be better
understood so adequate control meas-
ures can be developed.
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To the Editor: Each year, approx-
imately 2 million Muslims travel from
all over the world to participate in
hajj. Approximately 22,000 pilgrims
travel from the United Kingdom to
Makkah, Saudi Arabia; of those,
approximately 1,000 person reside in
the east end of London. In the past,
infectious diseases research conduct-
ed during these pilgrimages focused
on meningococcal disease because of
outbreaks associated with the hajj.
Since 2000, the dates of the hajj have
been moved back into the winter sea-
son; this time change could lead to a
seasonal increase in outbreaks of res-
piratory infections caused by influen-
za and other viruses. From 1991 to
1992, influenza A was a common
cause of respiratory infection in pil-
grims tested in Makkah (1).However,
the incidence rate of influenza among
pilgrims from Europe is not well-
known. Aprevious study of influenza-
like illness among pilgrims from
Pakistan reported rates of 36% in
influenza-vaccinated pilgrims and
62% in influenza-nonvaccinated pil-
grims; these results were based on
clinical endpoints without microbio-
logic confirmation (2).
We assessed the risk for influenza
infection among a cohort of pilgrims
from the east end of London who par-
ticipated in the hajj in 2003. From
December 2002 to January 2003, we
enrolled 115 participants who planned
to take part in hajj in 2003. The
study was approved by the North
London Multicentre Research Ethics
Committee and the Trustees of East
London Mosque. Informed consent
was obtained through appropriate
translators. All participants attended
the East London Mosque, White-
chapel, London; 30 were vaccinated
with influenza vaccine (A/New
Caledonia/20/99 [H1N1]-like strain, A
/Moscow/10/99 [H3N2]-like strain,
B/Sichuan/379/99-like strain). Venous
blood samples were collected, and
questionnaires were completed before
the participants departed for the hajj
and within 2–3 weeks of their return in
February to March 2003.
Tests for influenza A and B were
conducted by using hemagglutination